Flavonoids nanostructures promising therapeutic efficiencies in colorectal cancer

Xi, 2021, Global colorectal cancer burden in 2020 and projections to 2040, Transl. Oncol., 14, 10.1016/j.tranon.2021.101174 Almendingen, 2004, Dietary habits and growth and recurrence of colorectal adenomas: results from a three-year endoscopic follow-up study, Nutr. Cancer, 49, 131, 10.1207/s15327914nc4902_3 Mäkinen, 2007, Colorectal serrated adenocarcinoma, Histopathology, 50, 131, 10.1111/j.1365-2559.2006.02548.x Gulbake, 2016, Insight to drug delivery aspects for colorectal cancer, World J. Gastroenterol., 22, 582, 10.3748/wjg.v22.i2.582 Zeynali-Moghaddam, 2022, Combination of capecitabine, irinotecan and 17-AAG on expression of genes in HT-29 colorectal cancer cell line, Ann. Med. Surg., 10.1016/j.amsu.2022.103850 Mohammadian, 2017, Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines, Res. Pharm. Sci., 12, 517, 10.4103/1735-5362.217432 Gustavsson, 2015, A review of the evolution of systemic chemotherapy in the management of colorectal cancer, Clin. Colorectal Cancer, 14, 1, 10.1016/j.clcc.2014.11.002 Xiong, 2004, Treatment of colorectal cancer metastasis: the role of chemotherapy, Cancer Metastasis Rev., 23, 145, 10.1023/A:1025823315416 Kopustinskiene, 2020, Flavonoids as anticancer agents, Nutrients, 12, 457, 10.3390/nu12020457 Hasan, 2022, Synthetic pathways and the therapeutic potential of quercetin and curcumin, Int. J. Mol. Sci., 23, 14413, 10.3390/ijms232214413 Jeon, 2019, Regulation of the intracellular ROS level is critical for the antiproliferative effect of quercetin in the hepatocellular carcinoma cell line HepG2, Nutr. Cancer, 71, 861, 10.1080/01635581.2018.1559929 Liu, 2017, Effects of quercetin on proliferation and migration of human glioblastoma U251 cells, Biomed. Pharmacother., 92, 33, 10.1016/j.biopha.2017.05.044 Ai, 2017, Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-kappaB signaling, Oncotarget, 8, 100216, 10.18632/oncotarget.22145 Santandreu, 2011, Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells, Cell. Physiol. Biochem., 28, 219, 10.1159/000331733 Ashokkumar, 2008, Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis, Biomed. Pharmacother., 62, 590, 10.1016/j.biopha.2008.06.031 Belli, 2017, Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer, Oncotarget, 8, 68305, 10.18632/oncotarget.20054 Khan, 2021, Flavonoids nanoparticles in cancer: treatment, prevention and clinical prospects Fahimirad, 2019, Chapter 12 - nanocarrier-based antimicrobial phytochemicals, 299 Fahimirad, 2022, Wound healing performance of PVA/PCL based electrospun nanofiber incorporated green synthetized CuNPs and Quercus infectoria extracts, J. Biomater. Sci. Polym. Ed., 1 Kaushik, 2022, Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms, J. Nanobiotechnol., 20, 1, 10.1186/s12951-022-01364-2 Fahimirad, 2021, Antimicrobial activity, stability and wound healing performances of chitosan nanoparticles loaded recombinant LL37 antimicrobial peptide, Int. J. Pept. Res. Ther., 27, 2505, 10.1007/s10989-021-10268-y Maurya, 2019 Borse, 2022 Sharmiladevi, 2021, Nano-enabled theranostics for cancer, Mater. Adv., 2, 2876, 10.1039/D1MA00069A Lee, 2012, Multifunctional nanoparticles for multimodal imaging and theragnosis, Chem. Soc. Rev., 41, 2656, 10.1039/C2CS15261D Dong, 2011, Facile synthesis of monodisperse superparamagnetic Fe3O4 Core@ hybrid@ au shell nanocomposite for bimodal imaging and photothermal therapy, Adv. Mater., 23, 5392, 10.1002/adma.201103521 Huang, 2011, Graphene-based materials: synthesis, characterization, properties, and applications, Small, 7, 1876, 10.1002/smll.201002009 Yang, 2011, Convertible organic nanoparticles for near-infrared photothermal ablation of cancer cells, Angew. Chem. Int. Ed., 50, 441, 10.1002/anie.201005075 Zhang, 2011, Cationic polymer brush grafted-nanodiamond via atom transfer radical polymerization for enhanced gene delivery and bioimaging, J. Mater. Chem., 21, 7755, 10.1039/c1jm10813a Yang, 2007, Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer, Angew. Chem. Int. Ed., 46, 8836, 10.1002/anie.200703554 Lim, 2011, pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI, Adv. Mater., 23, 2436, 10.1002/adma.201100351 Dobrzynska, 2020, Flavonoid nanoparticles: a promising approach for cancer therapy, Biomolecules, 10, 1268, 10.3390/biom10091268 Ashrafizadeh, 2020, Apigenin as tumor suppressor in cancers: biotherapeutic activity, nanodelivery, and mechanisms with emphasis on pancreatic cancer, FrontiersChemistry, 8 Yan, 2017, Apigenin in cancer therapy: anti-cancer effects and mechanisms of action, Cell. Biosci., 7, 50, 10.1186/s13578-017-0179-x Fernández, 2021, Antiproliferative and palliative activity of flavonoids in colorectal cancer, Biomed. Pharmacother., 143, 10.1016/j.biopha.2021.112241 Lee, 2014, Apigenin-induced apoptosis is enhanced by inhibition of autophagy formation in HCT116 human colon cancer cells, Int. J. Oncol., 44, 1599, 10.3892/ijo.2014.2339 Turktekin, 2011, Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29), J. Med. Food, 14, 1107, 10.1089/jmf.2010.0208 Wang, 2017, Apigenin induces both intrinsic and extrinsic pathways of apoptosis in human colon carcinoma HCT-116 cells, Oncol. Rep., 37, 1132, 10.3892/or.2016.5303 Yang, 2021, Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells, Redox Biol., 47, 10.1016/j.redox.2021.102144 Zughaibi, 2021, Targeting PI3K/Akt/mTOR pathway by different flavonoids: a cancer chemopreventive approach, Int. J. Mol. Sci., 22, 10.3390/ijms222212455 Xu, 2016, Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the Wnt/β-catenin signaling pathway, Oncol. Lett., 11, 3075, 10.3892/ol.2016.4331 Ai, 2017, Apigenin inhibits colonic inflammation and tumorigenesis by suppressing STAT3-NF-κB signaling, Oncotarget, 8, 10.18632/oncotarget.22145 Zhang, 2021, Combined effect of chrysin and apigenin on inhibiting the development and progression of colorectal cancer by suppressing the activity of P38-MAPK/AKT pathway, IUBMB Life, 73, 774, 10.1002/iub.2456 Wang, 2011, Apigenin suppresses the growth of colorectal cancer xenografts via phosphorylation and up-regulated FADD expression, Oncol. Lett., 2, 43, 10.3892/ol.2010.215 Maeda, 2018, Apigenin induces apoptosis by suppressing bcl-xl and Mcl-1 simultaneously via signal transducer and activator of transcription 3 signaling in colon cancer, Int. J. Oncol., 52, 1661 Yuan, 2021, Apigenin inhibits the growth of colorectal cancer through down-regulation of E2F1/3 by miRNA-215-5p, Phytomedicine, 89, 153603, 10.1016/j.phymed.2021.153603 Shan, 2017, Apigenin restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase M2-dependent glycolysis, J. Agric. Food Chem., 65, 8136, 10.1021/acs.jafc.7b02757 Tong, 2019, Apigenin inhibits epithelial-mesenchymal transition of human colon cancer cells through NF-κB/Snail signaling pathway, Biosci. Rep., 39, 10.1042/BSR20190452 Sen, 2019, Dual drug loaded liposome bearing apigenin and 5-fluorouracil for synergistic therapeutic efficacy in colorectal cancer, Colloids Surf. B: Biointerfaces, 180, 9, 10.1016/j.colsurfb.2019.04.035 Butnariu, 2022, Naturally-occurring bioactives in Oral cancer: preclinical and clinical studies, bottlenecks and future directions, Front. Biosci.Sch., 14, 24, 10.31083/j.fbs1403024 Islam, 2022, Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases, Chemosphere, 307, 10.1016/j.chemosphere.2022.136020 Pham, 2015, Mitochondriotropic nanoemulsified genistein-loaded vehicles for cancer therapy, 85 Castaño, 2022, Development of genistein drug delivery systems based on bacterial nanocellulose for potential colorectal cancer chemoprevention: effect of nanocellulose surface modification on genistein adsorption, Molecules, 27, 7201, 10.3390/molecules27217201 Song, 2022, The preparation of gen-NH2-MCM-41@ SA nanoparticles and their anti-rotavirus effects, Pharmaceutics, 14, 1337, 10.3390/pharmaceutics14071337 Kamel, 2019, Multicompartmental lipid–protein nanohybrids for combined tretinoin/herbal lung cancer therapy, Nanomedicine, 14, 2461, 10.2217/nnm-2019-0090 Dutta, 2018, Encapsulation of nutraceutical ingredients in liposomes and their potential for cancer treatment, Nutr. Cancer, 70, 1184, 10.1080/01635581.2018.1557212 Hou, 2022, Genistein: therapeutic and preventive effects, mechanisms, and clinical application in digestive tract tumor, Evid. Based Complement. Alternat. Med., 2022, 10.1155/2022/5957378 Myoung, 2003, Anti-cancer effect of genistein in oral squamous cell carcinoma with respect to angiogenesis and in vitro invasion, Cancer Sci., 94, 215, 10.1111/j.1349-7006.2003.tb01422.x Sarkar, 2010, Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs, Curr. Pharm. Design, 16, 1801, 10.2174/138161210791208956 Liu, 2023, The lectin gene TRpL1 of tetraploid Robinia pseudoacacia L. response to salt stress, J. For. Res., 34, 497, 10.1007/s11676-022-01479-0 Zhang, 2015, Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells, Int. J. Nanomed., 10, 2461 Goh, 2022, Genistein: a review on its anti-inflammatory properties, Front. Pharmacol., 13, 10.3389/fphar.2022.820969 Li, 2022, A “Valve-closing” starvation strategy for amplification of tumor-specific chemotherapy, Adv. Sci., 9, 2104671, 10.1002/advs.202104671 Zhang, 2020, Overcoming cancer therapeutic bottleneck by drug repurposing, Signal Transduct. Target. Ther., 5, 113, 10.1038/s41392-020-00213-8 Pintova, 2019, Genistein combined with FOLFOX or FOLFOX–bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study, Cancer Chemother. Pharmacol., 84, 591, 10.1007/s00280-019-03886-3 Rendón, 2022, Evaluation of the effects of genistein in vitro as a chemopreventive agent for colorectal cancer—strategy to improve its efficiency when administered orally, Molecules, 27, 7042, 10.3390/molecules27207042 Pham, 2013, Mitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriers, Mol. Pharm., 10, 3789, 10.1021/mp4004892 Rahmani, 2020, Synthesis and characterisation of chitosan-encapsulated genistein: its anti-proliferative and anti-angiogenic activities, J. Microencapsul., 37, 305, 10.1080/02652048.2020.1740804 Nunes, 2020, Zein nanoparticles as low-cost, safe, and effective carriers to improve the oral bioavailability of resveratrol, Drug Deliv. Transl. Res., 10, 826, 10.1007/s13346-020-00738-z Islas-Weinstein, 2022, Immunomodulatory supplements, J. Encyclopedia Infect. Immun., 777, 10.1016/B978-0-12-818731-9.00132-4 Yammine, 2021, Polyphenols of the Mediterranean diet and their metabolites in the prevention of colorectal cancer, Molecules, 26, 10.3390/molecules26123483 Roshani, 2022, Applications of resveratrol in the treatment of gastrointestinal cancer, Biomed. Pharmacother., 153, 10.1016/j.biopha.2022.113274 Summerlin, 2016, Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol, Colloids Surf. B: Biointerfaces, 144, 1, 10.1016/j.colsurfb.2016.03.076 Vieira, 2022, Nano-delivery systems for food bioactive compounds in cancer: prevention, therapy, and clinical applications, Crit. Rev. Food Sci. Nutr., 1, 10.1080/10408398.2022.2106471 Jangid, 2020, Inulin-pluronic-stearic acid based double folded nanomicelles for pH-responsive delivery of resveratrol, Carbohydr. Polym., 247, 10.1016/j.carbpol.2020.116730 Schwingel, 2014, Effects of the compounds resveratrol, rutin, quercetin, and quercetin nanoemulsion on oxaliplatin-induced hepatotoxicity and neurotoxicity in mice, Naunyn Schmiedebergs Arch. Pharmacol., 387, 837, 10.1007/s00210-014-0994-0 Md, 2021, Development, optimization, and in vitro evaluation of novel Oral long-acting resveratrol nanocomposite in-situ gelling film in the treatment of colorectal cancer, Gels, 7, 10.3390/gels7040276 Zhang, 2011, Fluorinated N, N-dialkylaminostilbenes for wnt pathway inhibition and colon cancer repression, J. Med. Chem., 54, 1288, 10.1021/jm101248v Zhang, 2022, Ferroptosis-induced anticancer effect of resveratrol with a biomimetic nano-delivery system in colorectal cancer treatment, Asian. J. Pharm. Sci., 17, 751, 10.1016/j.ajps.2022.07.006 Nguyen, 2009, Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer, Cancer Manag. Res., 25 Jang, 2022, Mechanism of resveratrol-induced programmed cell death and new drug discovery against cancer: a review, Int. J. Mol. Sci., 23, 13689, 10.3390/ijms232213689 Khayat, 2022, Intensification of resveratrol cytotoxicity, pro-apoptosis, oxidant potentials in human colorectal carcinoma HCT-116 cells using zein nanoparticles, Sci. Rep., 12, 15235, 10.1038/s41598-022-18557-2 Prezotti, 2020, Oral nanoparticles based on gellan gum/pectin for colon-targeted delivery of resveratrol, Drug Dev. Ind. Pharm., 46, 236, 10.1080/03639045.2020.1716374 Jin, 2019, Potential of utilization of albumin as a delivery module in cancer model, J. Buon., 24, 347 Kamal, 2018, Physiological uptake and retention of radiolabeled resveratrol loaded gold nanoparticles (99mTc-res-AuNP) in colon cancer tissue, Nanomedicine, 14, 1059, 10.1016/j.nano.2018.01.008 Serini, 2018, Omega-3 PUFA loaded in resveratrol-based solid lipid nanoparticles: physicochemical properties and antineoplastic activities in human colorectal cancer cells in vitro, Int. J. Mol. Sci., 19, 586, 10.3390/ijms19020586 Samprasit, 2022, Alpha-mangostin and resveratrol, dual-drugs-loaded mucoadhesive thiolated chitosan-based nanoparticles for synergistic activity against colon cancer cells, J. Biomed. Mater. Res. B Appl. Biomater., 110, 1221, 10.1002/jbm.b.34992 Kuo, 2020, Potential enhancement of host immunity and anti-tumor efficacy of nanoscale curcumin and resveratrol in colorectal cancers by modulated electro-hyperthermia, BMC Cancer, 20, 1, 10.1186/s12885-020-07072-0 Kumar, 2020, Targeted delivery and apoptosis induction of trans-resveratrol-ferulic acid loaded chitosan coated folic acid conjugate solid lipid nanoparticles in colon cancer cells, Carbohydr. Polym., 231 Jung, 2015, Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo, Int. J. Pharm., 478, 251, 10.1016/j.ijpharm.2014.11.049 Wang, 2021, In vitro and in vivo combinatorial anticancer effects of oxaliplatin-and resveratrol-loaded N, O-carboxymethyl chitosan nanoparticles against colorectal cancer, Eur. J. Pharm. Sci., 163, 10.1016/j.ejps.2021.105864 Sudha, 2020, Resveratrol and its nanoformulation attenuate growth and the angiogenesis of xenograft and orthotopic colon cancer models, Molecules, 25, 10.3390/molecules25061412 Khater, 2022, Therapeutic potential of quercetin loaded nanoparticles: novel insights in alleviating colitis in an experimental DSS induced colitis model, Biomedicines, 10, 10.3390/biomedicines10071654 Sun, 2022, A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer, Acta Pharm. Sin. B, 12, 378, 10.1016/j.apsb.2021.06.005 Alhakamy, 2021, Scorpion venom-functionalized quercetin phytosomes for breast cancer management: in vitro response surface optimization and anticancer activity against MCF-7 cells, Polymers (Basel), 14, 10.3390/polym14010093 Diez-Echave, 2021, Silk fibroin nanoparticles enhance quercetin immunomodulatory properties in DSS-induced mouse colitis, Int. J. Pharm., 606, 10.1016/j.ijpharm.2021.120935 Mishra, 2020, Folic acid-conjugated magnetic mesoporous silica nanoparticles loaded with quercetin: a theranostic approach for cancer management, RSC Adv., 10, 23148, 10.1039/D0RA00664E Mihanfar, 2021, Therapeutic potential of quercetin in an animal model of PCOS: possible involvement of AMPK/SIRT-1 axis, Eur. J. Pharmacol., 900, 10.1016/j.ejphar.2021.174062 Kim, 2014, Quercetin regulates the sestrin 2-AMPK-p38 MAPK signaling pathway and induces apoptosis by increasing the generation of intracellular ROS in a p53-independent manner, Int. J. Mol. Med., 33, 863, 10.3892/ijmm.2014.1658 Abd-Rabou, 2017, CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: a novel approach for induction of apoptosis in HepG2 cell line, Adv. Med. Sci., 62, 357, 10.1016/j.advms.2017.01.003 Tang, 2020, Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects, Biomed. Pharmacother., 121, 10.1016/j.biopha.2019.109604 Moon, 2021, Nano-encapsulated quercetin by soluble soybean polysaccharide/chitosan enhances anti-cancer, anti-inflammation, and anti-oxidant activities, J. Funct. Foods, 87, 10.1016/j.jff.2021.104756 Li, 2009, Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles, J. Control. Release, 133, 238, 10.1016/j.jconrel.2008.10.002 Tran, 2014, Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability, J. Pharm. Sci., 103, 840, 10.1002/jps.23858 Castangia, 2015, Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats, Acta Biomater., 13, 216, 10.1016/j.actbio.2014.11.017 Xu, 2015, Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles, Int. J. Nanomed., 10, 2051 Ray, 2017, Synergism of co-delivered nanosized antioxidants displayed enhanced anticancer efficacy in human colon cancer cell lines, Bioact. Mater., 2, 82, 10.1016/j.bioactmat.2017.02.003 Zhang, 2019, Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer, ACS Nano, 13, 12511, 10.1021/acsnano.9b02875 Sunoqrot, 2019, Bioinspired polymerization of quercetin to produce a curcumin-loaded nanomedicine with potent cytotoxicity and cancer-targeting potential in vivo, ACS Biomater. Sci. Eng., 5, 6036, 10.1021/acsbiomaterials.9b01240 Colpan, 2021, Co-delivery of quercetin and caffeic-acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells, J. Microencapsul., 38, 381, 10.1080/02652048.2021.1948623 Liu, 2022, Combined and targeted drugs delivery system for colorectal cancer treatment: conatumumab decorated, reactive oxygen species sensitive irinotecan prodrug and quercetin co-loaded nanostructured lipid carriers, Drug Deliv., 29, 342, 10.1080/10717544.2022.2027573 Rashedi, 2019, Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in wistar rats, Adv. Pharm. Bull., 9, 409, 10.15171/apb.2019.048 Shao, 2019, Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance, Colloids Surf. B: Biointerfaces, 183, 10.1016/j.colsurfb.2019.110427 Wen, 2018, A colon-specific delivery system for quercetin with enhanced cancer prevention based on co-axial electrospinning, Food Funct., 9, 5999, 10.1039/C8FO01216D Yilmaz, 2019, Inclusion of quercetin in gold nanoparticles decorated with supramolecular hosts amplifies its tumor targeting properties, ACS Appl. Bio Mater., 2, 2715, 10.1021/acsabm.8b00748 Kubina, 2022, Fisetin, a potent anticancer flavonol exhibiting cytotoxic activity against neoplastic malignant cells and cancerous conditions: a scoping, comprehensive review, Nutrients, 14, 10.3390/nu14132604 Kulbacka, 2016, Electroporation and lipid nanoparticles with cyanine IR-780 and flavonoids as efficient vectors to enhanced drug delivery in colon cancer, Bioelectrochemistry, 110, 19, 10.1016/j.bioelechem.2016.02.013 Mihanfar, 2021, Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome, J. Steroid Biochem. Mol. Biol., 213, 10.1016/j.jsbmb.2021.105954 Feng, 2019, Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy, Int. J. Biol. Macromol., 125, 700, 10.1016/j.ijbiomac.2018.12.003 Chen, 2015, Polymeric micelles encapsulating fisetin improve the therapeutic effect in colon cancer, ACS Appl. Mater. Interfaces, 7, 534, 10.1021/am5066893 Bai, 2021, Gallic acid: pharmacological activities and molecular mechanisms involved in inflammation-related diseases, Biomed. Pharmacother., 133, 10.1016/j.biopha.2020.110985 Hassani, 2020, Preparation, characterization and therapeutic properties of gum arabic-stabilized gallic acid nanoparticles, Sci. Rep., 10, 17808, 10.1038/s41598-020-71175-8 Liu, 2019, Inhibition of polypeptide N-acetyl-α-galactosaminyltransferases is an underlying mechanism of dietary polyphenols preventing colorectal tumorigenesis, Bioorg. Med. Chem., 27, 3372, 10.1016/j.bmc.2019.06.020 Santos, 2013, Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer, Biotechnol. Adv., 31, 514, 10.1016/j.biotechadv.2012.08.005 Rosman, 2018, Improved anticancer effect of magnetite nanocomposite formulation of GALLIC acid (Fe₃O₄-PEG-GA) against lung, breast and colon cancer cells, Nanomaterials (Basel), 8, 10.3390/nano8020083 Klebowski, 2020, Fancy-shaped gold-platinum nanocauliflowers for improved proton irradiation effect on colon cancer cells, Int. J. Mol. Sci., 21, 10.3390/ijms21249610 El-Garhy, 2022, Dietary supplementation of Silybum marianum seeds improved growth performance and upregulated associated gene expression of Muscovy ducklings (Cairina moschata), Antioxidants, 11, 2300, 10.3390/antiox11112300 Koltai, 2022, Role of silymarin in cancer treatment: facts, hypotheses, and questions, J. Evid. Based Integr. Med., 27, 10.1177/2515690X211068826 Mastron, 2015, Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review, Anti-Cancer Drugs, 26, 475, 10.1097/CAD.0000000000000211 Malekinejad, 2014, Effects of silymarin on the pharmacokinetics of atorvastatin in diabetic rats, Eur. J. Drug Metab. Pharmacokinet., 39, 311, 10.1007/s13318-013-0166-5 Flaig, 2007, Silibinin synergizes with mitoxantrone to inhibit cell growth and induce apoptosis in human prostate cancer cells, Int. J. Cancer, 120, 2028, 10.1002/ijc.22465 Li, 2011, Molecular mechanism of silymarin-induced apoptosis in a highly metastatic lung cancer cell line anip973, Cancer Biother. Radiopharm., 26, 317 Singh, 2016, Therapeutic intervention of silymarin on the migration of non-small cell lung cancer cells is associated with the axis of multiple molecular targets including class 1 HDACs, ZEB1 expression, and restoration of miR-203 and E-cadherin expression, Am. J. Cancer Res., 6, 1287 Kim, 2021, Silymarin inhibits proliferation of human breast cancer cells via regulation of the MAPK signaling pathway and induction of apoptosis, Oncol. Lett., 21, 1, 10.3892/ol.2021.12753 Ramasamy, 2008, Multitargeted therapy of cancer by silymarin, Cancer Lett., 269, 352, 10.1016/j.canlet.2008.03.053 Fehér, 2012, Silymarin in the prevention and treatment of liver diseases and primary liver cancer, Curr. Pharm. Biotechnol., 13, 210, 10.2174/138920112798868818 Fan, 2014, Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells, Eur. J. Pharmacol., 743, 79, 10.1016/j.ejphar.2014.09.019 Tyagi, 2007, Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine–induced urinary bladder carcinogenesis in male ICR mice, Mol. Cancer Ther., 6, 3248, 10.1158/1535-7163.MCT-07-2006 Theodosiou, 2014, Bioavailability of silymarin flavonolignans: drug formulations and biotransformation, Phytochem. Rev., 13, 1, 10.1007/s11101-013-9285-5 Jackson, 2020, Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells, Bioinformation, 16, 817, 10.6026/97320630016817 Mombeini, 2018, Effects of silymarin-loaded nanoparticles on HT-29 human colon cancer cells, Medicina, 54, 1, 10.3390/medicina54010001 Radu, 2017, Poly (hydroxybutyrate-co-hydroxyvalerate)(PHBHV) nanocarriers for silymarin release as adjuvant therapy in Colo-rectal cancer, Front. Pharmacol., 8, 508, 10.3389/fphar.2017.00508 Lin, 2008, Luteolin, a flavonoid with potential for cancer prevention and therapy, Curr. Cancer Drug Targets, 8, 634, 10.2174/156800908786241050 Zuo, 2018, The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells, J. Cell. Biochem., 119, 9573, 10.1002/jcb.27275 Ambasta, 2019, Can luteolin be a therapeutic molecule for both colon cancer and diabetes?, Brief. Funct. Genomics, 18, 230, 10.1093/bfgp/ely036 Yao, 2019, Luteolin suppresses colorectal cancer cell metastasis via regulation of the miR-384/pleiotrophin axis, Oncol. Rep., 42, 131, 10.3892/or.2021.8082 Liu, 2017, Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study, J. Proteome, 161, 1, 10.1016/j.jprot.2017.04.005 Chiang, 2021, From nanoparticles to cancer nanomedicine: old problems with new solutions, Nanomaterials, 11, 1727, 10.3390/nano11071727 Braicu, 2013, The relationship between the structure and biological actions of green tea catechins, Food Chem., 141, 3282, 10.1016/j.foodchem.2013.05.122 Aggarwal, 2022, Molecular mechanisms of action of epigallocatechin gallate in cancer: recent trends and advancement, Semin. Cancer Biol., 80, 256, 10.1016/j.semcancer.2020.05.011 Ferruzzi, 2010, The influence of beverage composition on delivery of phenolic compounds from coffee and tea, Physiol. Behav., 100, 33, 10.1016/j.physbeh.2010.01.035 Du, 2012, Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea, Nutrients, 4, 1679, 10.3390/nu4111679 Suzuki, 2016, Health benefits of tea consumption, 49 Hayakawa, 2018, Tea, coffee and health benefits, 1 Green, 2007, Common tea formulations modulate in vitro digestive recovery of green tea catechins, Mol. Nutr. Food Res., 51, 1152, 10.1002/mnfr.200700086 Yang, 2006, Possible mechanisms of the cancer-preventive activities of green tea, Mol. Nutr. Food Res., 50, 170, 10.1002/mnfr.200500105 Araújo, 2011, Chemopreventive effect of dietary polyphenols in colorectal cancer cell lines, Nutr. Res., 31, 77, 10.1016/j.nutres.2011.01.006 Farabegoli, 2022, Epigallocatechin-3-gallate delivery in lipid-based nanoparticles: potentiality and perspectives for future applications in cancer chemoprevention and therapy, Front. Pharmacol., 13, 10.3389/fphar.2022.809706 Safwat, 2020, Epigallocatechin-3-gallate-loaded gold nanoparticles: preparation and evaluation of anticancer efficacy in Ehrlich tumor-bearing mice, Pharmaceuticals (Basel), 13, 10.3390/ph13090254 Singh, 2011, Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications, Biochem. Pharmacol., 82, 1807, 10.1016/j.bcp.2011.07.093 Wang, 2020, Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats, World J. Gastroenterol., 26, 2064, 10.3748/wjg.v26.i17.2064 Gan, 2018, Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review, Crit. Rev. Food Sci. Nutr., 58, 924, 10.1080/10408398.2016.1231168 Khan, 2018, Tea polyphenols in promotion of human health, Nutrients, 11, 39, 10.3390/nu11010039 Ohishi, 2016, Anti-inflammatory action of green tea, Antiinflamm. Antiallergy Agents Med. Chem., 15, 74, 10.2174/1871523015666160915154443 Chen, 2018, The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway, Int. J. Mol. Sci., 19, 2729, 10.3390/ijms19092729 Shimizu, 2010, (−)-epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells, Chem. Biol. Interact., 185, 247, 10.1016/j.cbi.2010.03.036 Jin, 2013, Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating notch signaling, Onco Targets Ther., 6, 145, 10.2147/OTT.S40914 Alam, 2022, Epigallocatechin 3-gallate: from green tea to cancer therapeutics, Food Chem., 379, 10.1016/j.foodchem.2022.132135 Ding, 2021, Epigallocatechin-3-gallate inhibits proliferation and triggers apoptosis in colon cancer via the hedgehog/phosphoinositide 3-kinase pathways, Can. J. Physiol. Pharmacol., 99, 910, 10.1139/cjpp-2020-0588 Das, 2010, Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes, Cancer, 116, 164, 10.1002/cncr.24699 Wang, 2019, Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3-gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles, Nanomedicine, 21 Moracci, 2022, An investigation on [5 fluorouracil and epigallocatechin-3-gallate] complex activity on HT-29 cell death and its stability in gastrointestinal fluid, Oncotarget, 13, 476, 10.18632/oncotarget.28207 Zhang, 2013, Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages, J. Agric. Food Chem., 61, 9200, 10.1021/jf4023004 Dube, 2010, Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate, Eur. J. Pharm. Sci., 41, 219, 10.1016/j.ejps.2010.06.010 Wang, 2012, Effect of celecoxib on Ca2+ handling and viability in human prostate cancer cells (PC3), Drug Chem. Toxicol., 35, 456, 10.3109/01480545.2011.638927 Smith, 2010, Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease, Int. J. Pharm., 389, 207, 10.1016/j.ijpharm.2010.01.012 Chow, 2005, Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals, Clin. Cancer Res., 11, 4627, 10.1158/1078-0432.CCR-04-2549 Li, 2014, Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells, Food Funct., 5, 1278, 10.1039/c3fo60500k Calibasi-Kocal, 2019, Curcumin effects on cell proliferation, angiogenesis and metastasis in colorectal cancer, J. Buon., 24, 1482 Willenbacher, 2019, Curcumin: new insights into an ancient ingredient against cancer, Int. J. Mol. Sci., 20, 10.3390/ijms20081808 Eke-Okoro, 2018, Curcumin in turmeric: basic and clinical evidence for a potential role in analgesia, J. Clin. Pharm. Ther., 43, 460, 10.1111/jcpt.12703 Fahimirad, 2021, Wound healing performance of PCL/chitosan based electrospun nanofiber electrosprayed with curcumin loaded chitosan nanoparticles, Carbohydr. Polym., 259, 10.1016/j.carbpol.2021.117640 Naeini, 2019, Antitumor effects of curcumin: a lipid perspective, J. Cell. Physiol., 234, 14743, 10.1002/jcp.28262 Kabir, 2021, Potential role of curcumin and its nanoformulations to treat various types of cancers, Biomolecules, 11, 392, 10.3390/biom11030392 Karthika, 2021, Curcumin as a great contributor for the treatment and mitigation of colorectal cancer, Exp. Gerontol., 152, 10.1016/j.exger.2021.111438 Sun, 2012, Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy, J. Hematol. Oncol., 5, 1, 10.1186/1756-8722-5-63 Allegra, 2017, Anticancer activity of curcumin and its analogues: preclinical and clinical studies, Cancer Investig., 35, 1, 10.1080/07357907.2016.1247166 Pricci, 2020, Curcumin and colorectal cancer: from basic to clinical evidences, Int. J. Mol. Sci., 21, 2364, 10.3390/ijms21072364 Jiao, 2009, Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator, Blood, 113, 462, 10.1182/blood-2008-05-155952 Howells, 2011, Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo, Int. J. Cancer, 129, 476, 10.1002/ijc.25670 Huang, 2017, Curcumin enhances the effects of irinotecan on colorectal cancer cells through the generation of reactive oxygen species and activation of the endoplasmic reticulum stress pathway, Oncotarget, 8, 40264, 10.18632/oncotarget.16828 Siddiqui, 2009, Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice, Br. J. Nutr., 102, 967, 10.1017/S0007114509345250 Liu, 2022, MnO2-shelled doxorubicin/curcumin nanoformulation for enhanced colorectal cancer chemo-immunotherapy, J. Colloid Interface Sci., 617, 315, 10.1016/j.jcis.2022.02.132 Cruz, 1998, Oral administration of rutoside can ameliorate inflammatory bowel disease in rats, Life Sci., 62, 687, 10.1016/S0024-3205(97)01164-8 Asgharian, 2020, Ruta graveolens and rutin, as its major compound: investigating their effect on spatial memory and passive avoidance memory in rats, Pharm. Biol., 58, 447, 10.1080/13880209.2020.1762669 Pandey, 2021, Rutin (Bioflavonoid) as cell signaling pathway modulator: prospects in treatment and chemoprevention, Pharmaceuticals, 14, 1069, 10.3390/ph14111069 Yang, 2008, In vitro antioxidant properties of rutin, LWT-Food Sci. Technol., 41, 1060, 10.1016/j.lwt.2007.06.010 Almeida, 2010, Nanostructured systems containing rutin: in vitro antioxidant activity and photostability studies, Nanoscale Res. Lett., 5, 1603, 10.1007/s11671-010-9683-1 Peng, 2018, The application of deep eutectic solvent on the extraction and in vitro antioxidant activity of rutin from Sophora japonica bud, J. Food Sci. Technol., 55, 2326, 10.1007/s13197-018-3151-9 Rodríguez-Valdovinos, 2021, Quantitative analysis of rutin by HPTLC and in vitro antioxidant and antibacterial activities of phenolic-rich extracts from Verbesina sphaerocephala, Plants, 10, 475, 10.3390/plants10030475 Perk, 2014, Rutin mediated targeting of signaling machinery in cancer cells, Cancer Cell Int., 14, 1, 10.1186/s12935-014-0124-6 Paudel, 2021, Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro, Life Sci., 276, 10.1016/j.lfs.2021.119436 Hoai, 2020, Evaluation of the cytotoxic effect of rutin prenanoemulsion in lung and colon cancer cell lines, J. Nanomater., 2020, 10.1155/2020/8867669 Firouzai-Amandi, 2022, Development, characterization, and in vitro evaluation of cytotoxic activity of rutin loaded PCL-PEG nanoparticles against Skov3 ovarian cancer cell, Asian Pac. J. Cancer Prev., 23, 1951, 10.31557/APJCP.2022.23.6.1951 Guon, 2016, Hyperoside and rutin of Nelumbo nucifera induce mitochondrial apoptosis through a caspase-dependent mechanism in HT-29 human colon cancer cells, Oncol. Lett., 11, 2463, 10.3892/ol.2016.4247 Alonso-Castro, 2013, Rutin exerts antitumor effects on nude mice bearing SW480 tumor, Arch. Med. Res., 44, 346, 10.1016/j.arcmed.2013.06.002 Deschner, 1991, Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia, Carcinogenesis, 12, 1193, 10.1093/carcin/12.7.1193 ben Sghaier, 2016, Rutin inhibits proliferation, attenuates superoxide production and decreases adhesion and migration of human cancerous cells, Biomedicine & Pharmacotherapy, 84, 1972, 10.1016/j.biopha.2016.11.001 Nafees, 2018, Synergistic interaction of rutin and silibinin on human colon cancer cell line, Arch. Med. Res., 49, 226, 10.1016/j.arcmed.2018.09.008 Asfour, 2018, Formulation and evaluation of pH-sensitive rutin nanospheres against colon carcinoma using HCT-116 cell line, J. Adv. Res., 9, 17, 10.1016/j.jare.2017.10.003 Ferreira, 2022, Flavonoids-based delivery systems towards cancer therapies, Bioengineering, 9, 197, 10.3390/bioengineering9050197 Ponte, 2021, The hallmarks of flavonoids in cancer, Molecules, 26, 2029, 10.3390/molecules26072029 Li, 2019, AuNPs as an important inorganic nanoparticle applied in drug carrier systems, Artif. Cells Nanomed. Biotechnol., 47, 4222, 10.1080/21691401.2019.1687501 Nejati, 2021, Biomedical applications of functionalized gold nanoparticles: a review, J. Clust. Sci., 1 Jasim, 2022, Preliminary trials of the gold nanoparticles conjugated chrysin: an assessment of anti-oxidant, anti-microbial, and in vitro cytotoxic activities of a nanoformulated flavonoid, Nanotechnol. Rev., 11, 2726, 10.1515/ntrev-2022-0153 Rehman, 2022, Microenvironmental behaviour of nanotheranostic systems for controlled oxidative stress and cancer treatment, Nanomaterials, 12, 2462, 10.3390/nano12142462 Sulaiman, 2020, Hesperidin loaded on gold nanoparticles as a drug delivery system for a successful biocompatible, anti-cancer, anti-inflammatory and phagocytosis inducer model, Sci. Rep., 10, 9362, 10.1038/s41598-020-66419-6 Yeh, 2011, Gallic acid induces G₀/G₁ phase arrest and apoptosis in human leukemia HL-60 cells through inhibiting cyclin D and E, and activating mitochondria-dependent pathway, Anticancer Res., 31, 2821 Karimi, 2011, "Silymarin", a promising pharmacological agent for treatment of diseases, Iran. J. Basic Med. Sci., 14, 308 Wu, 2018, Liposome encapsulated luteolin showed enhanced antitumor efficacy to colorectal carcinoma, Mol. Med. Rep., 17, 2456